International Stem Cell Corporation announced that its oocyte collection and activation protocol has received the approval of an Institutional Review Board, a Federal requirement for all studies enrolling human subjects, and ensures appropriate subj

International Stem Cell Corporation announced that the United States Patent and Trademark Office has granted ISCO a patent relating to the company's development of human non-embryonic parthenogenetic stem cells. Human parthenogenetic stem cells are

International Stem Cell Corporation, an international pioneer and leader in stem cell research, announced that its wholly owned subsidiary, Lifeline Skin Care Inc., has achieved positive results in human safety tests of its cosmetic products and is m